Cereno Scientific AB (FRA:4A1) Ending Cash Position : €6.50 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cereno Scientific AB Ending Cash Position?

Cereno Scientific AB's Ending Cash Position for the quarter that ended in Sep. 2024 was €6.50 Mil.

Cereno Scientific AB's quarterly Ending Cash Position increased from Mar. 2024 (€4.35 Mil) to Jun. 2024 (€7.58 Mil) but then declined from Jun. 2024 (€7.58 Mil) to Sep. 2024 (€6.50 Mil).

Cereno Scientific AB's annual Ending Cash Position declined from Dec. 2021 (€8.73 Mil) to Dec. 2022 (€6.10 Mil) but then increased from Dec. 2022 (€6.10 Mil) to Dec. 2023 (€7.79 Mil).

Cereno Scientific AB Ending Cash Position Historical Data

The historical data trend for Cereno Scientific AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Ending Cash Position Chart

Cereno Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2.49

6.49

8.73

6.10

7.79

Cereno Scientific AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															5.79	7.79	4.35	7.58	6.50

Cereno Scientific AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cereno Scientific AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5.994	+	1.799
	=	7.79

Cereno Scientific AB's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7.54	+	-1.036
	=	6.50

Cereno Scientific AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cereno Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (FRA:4A1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

CRNO B:Sweden

Address

BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.cerenoscientific.se

Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines